GCG and diabetes mellitus: Likely, both the presence of different DPP-4-targets than GLP-1 and the absence of GLP-1 degradative molecules [i.e., GLP-1(9-36), GLP-1(28-36)] may affect cardiovascular pathophysiology in diabetes.